Oakville, Canada

Uli Christian Broedl

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Uli Christian Broedl: Innovator in Pharmaceutical Composition

Introduction

Uli Christian Broedl is a prominent inventor based in Oakville, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of chronic kidney disease and diabetes. With a total of 2 patents, his work has the potential to impact many patients suffering from these conditions.

Latest Patents

Broedl's latest patents include innovative methods for treating chronic kidney disease and cardiovascular disease. One patent focuses on administering empagliflozin to patients with chronic kidney disease. The second patent involves a pharmaceutical composition that combines an SGLT2 inhibitor, a DPPIV inhibitor, and a third antidiabetic agent. This composition is designed to treat or prevent conditions such as type 1 and type 2 diabetes mellitus, impaired glucose tolerance, and hyperglycemia.

Career Highlights

Uli Christian Broedl is associated with Boehringer Ingelheim International GmbH, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Some of his notable coworkers include Maximilian Von Eynatten and Hans-Juergen Woerle, who collaborate with him on various projects within the pharmaceutical field.

Conclusion

Uli Christian Broedl's contributions to pharmaceutical innovation are noteworthy, particularly in the treatment of chronic diseases. His patents reflect a dedication to enhancing therapeutic options for patients, showcasing the importance of research and development in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…